SEC Form 4 · accession 0001250853-15-000109
IOVANCE BIOTHERAPEUTICS, INC. · IOVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Molly Henderson
Officer — Chief Financial Officer
Period of report
Dec 28, 2015
Accepted (ET)
Dec 30, 2015 · 3:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001425205
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $7.58 | Dec 28, 2015 | A | 21,116 | A | — | Dec 27, 2025 | Common Stock | 21,116 | 21,116 | D |
Explanation of responses
- F1One third of the shares underlying the option shall vest on December 28, 2016; and the remaining shares shall vest in eight equal quarterly installments over the next two years after the first anniversary of the grant date of December 28, 2015, provided the Reporting Person is still providing services to the Issuer on the respective dates.